Mohammed Amran | Product Innovation | Young Researcher Award

Published on by Network Science

Mr. Mohammed Amran | Product Innovation | Young Researcher Award

The University of Dodoma | Tanzania

Mr. Mohammed A. Amran is a dedicated chemist and researcher specializing in organic and sustainable materials. He earned his Bachelor of Science in Chemistry from the University of Dodoma (UDOM), where he received the Overall Best Project in Chemistry Award in 2022 for his outstanding research achievements. Continuing his academic journey, he completed a Master of Science in Chemistry with a specialization in organic materials at the State University of Zanzibar (SUZA) in December 2024. Mr. Amran’s pioneering research on seaweed-based bioplastics, under the project “The Potential of Native Seaweed as an Alternative Source of Bioplastic to Mitigate Climate Change,” earned him recognition and led to a granted patent titled “A Seaweed-Based Renewable Resources Bioplastic and Production Methods Thereof” (Patent No. TZ/P/2024/00105). He currently serves as an Assistant Lecturer at UDOM (2025–present), specializing in material sciences and organic materials, having previously worked as a Tutorial Assistant in Organic Chemistry (2023–2024). His professional experience also includes roles as Assistant Quality Controller at Lootah Group of Companies in Zanzibar and Senior Census Clerk at the National Bureau of Statistics during Tanzania’s 2022 national census. Mr. Amran has presented his research at leading forums such as the International Conference in Science, Technology, and Innovation (ICST) in Dodoma (2024) and the 9th STICE Conference in Dar es Salaam, contributing to the advancement of renewable packaging materials. Skilled in forensic chemical analysis, natural polymer extraction, quality control, and sustainable material synthesis, he has further honed his expertise through certified courses offered by Elsevier’s Researcher Academy and other industrial training programs. A multidisciplinary researcher, Mr. Amran’s work lies at the intersection of environmental sustainability, green chemistry, polymer science, and renewable materials, with a vision to combat plastic pollution and climate change through innovative bioplastic technologies and cross-sectoral collaboration.

Profiles: Scopus

Featured Publications

"Assessment of baseline physicochemical qualities of carrageenan-based bioplastics from Kappaphycus alvarezii seaweed for their packaging applications"

Edwin Tonderai Mombeshora | Energy Materials | Best Researcher Award

Published on by Network Science

Dr. Edwin Tonderai Mombeshora | Energy Materials | Best Researcher Award

University of Pretoria | South Africa

Dr. Edwin Tonderai Mombeshora is a materials chemist and academic currently serving as Lecturer in Physical Chemistry at the University of Pretoria (since January 2025), where he teaches undergraduate and postgraduate courses, supervises honours and postgraduate students, and coordinates second-year Physical Chemistry practicals, with a research focus on materials development and physicochemical characterization for energy storage applications. He previously lectured in Physical and Materials Chemistry at the University of Zimbabwe (2022–2024) and held several research positions, including Postdoctoral Fellowships at the University of KwaZulu-Natal, Swansea University, and the University of the Witwatersrand, specializing in nanomaterials science, electrochemical energy storage systems, biorefinery, and energy conversion. Dr. Mombeshora earned his PhD (2018) and MSc (2015) in Materials Chemistry from the University of KwaZulu-Natal and a BSc Honours in Chemistry (2011) from the University of Zimbabwe. His expertise spans nanotechnology, carbon materials, and energy devices such as solar cells and supercapacitors. He is the recipient of several prestigious fellowships and research grants, including awards from the Water Research Commission, the Australia Africa Universities Network, and the University of Johannesburg’s Global Excellence Stature Fellowship, as well as the SACI Postgraduate Award (2018). Dr. Mombeshora has supervised and mentored students across undergraduate, MSc, and PhD levels, contributed to international conferences, served as guest editor for MDPI’s Processes, and co-authored research articles in leading journals such as RSC Materials Advances, Journal of Materials Science, and Journal of Nanobiotechnology. He is also co-inventor of a US-patented electroconductive composite (2020) and an active member of professional bodies including the Royal Society of Chemistry (RSC) and the South African Chemical Institute (SACI).

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Pristine graphene oxide treatment of wastewater from a typical sub-tropical mine in Chegutu, Zimbabwe"

"Towards high-performance dye-sensitized solar cells by utilizing reduced graphene oxide-based composites as potential alternatives to conventional electrodes: A review"

"The prospects of biologically derived materials in perovskite solar cells"

"Towards high-performance lithium-ion batteries by introducing graphene-based materials into LiFePO4 cathodes: A review"

"Dynamics of reduced graphene oxide: synthesis and structural models"

Mahdieh Azizian | Machine Learning | Best Researcher Award

Published on by Network Science

Dr. Mahdieh Azizian | Machine Learning | Best Researcher Award

Kerman University of Medical Sciences | Iran

Dr. Mahdieh Azizian is an accomplished scholar in Applied Mathematics with a Ph.D. in Numerical Analysis from Shahid Bahonar University of Kerman, where her doctoral research focused on optimizing dynamical models of tumor control using fuzzy dynamical systems. Building on her earlier M.Sc. and B.Sc. degrees in Applied Mathematics from the same university, she has developed a strong expertise in mathematical modeling, bioinformatics, epidemiology, and cancer research. Over the years, Dr. Azizian has actively contributed as a lecturer and workshop instructor in numerous national and international academic forums, covering topics such as cancer mathematical modeling, numerical methods, data mining, and interdisciplinary applications of mathematics in medical sciences. She has also held key academic and administrative roles, including membership in the Research Council of the School of Medicine and serving as Superintendent of the Statistics Department at Kerman University of Medical Sciences. Recognized for her teaching excellence, she was honored as a Superior Instructor in 2014, in addition to receiving distinctions as a top student during her academic studies. Through her extensive teaching, research, and administrative experiences, Dr. Azizian has established herself as a dedicated educator and researcher at the intersection of mathematics and medical sciences.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"An interval version of Black–Scholes European option pricing model and its numerical solution"

"Time Series Model for Forecasting the Prevalence of Some Important Parasitic Infections in Slaughtered Sheep in North-Central Iran"

"Estimating the Number of COVID-19 Cases and Impact of New COVID-19 Variants and Vaccination on the Population in Kerman, Iran: A Mathematical Modeling Study"

"A Brief History of Listening Comprehension in Second Language Teaching and Learning"

"An Empirical Study on the Effects of Using Kahoot as a Game-Based Learning Tool on EFL Learners’ Vocabulary Recall and Retention"

Orhan Özturan | Research | Best Researcher Award

Published on by Network Science

Prof Orhan Özturan | Research | Best Researcher Award

Bezmialem Vakif University | Turkey

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. Orhan Özturan, born in Gaziantep in 1961, displayed academic excellence from an early stage. After graduating from Private Adana College in 1978, he pursued medical education at Hacettepe University, later transferring to Erciyes University, Faculty of Medicine, where he graduated as the second-highest-ranked student. His strong foundation in medicine set the stage for his specialization and subsequent contributions to the field of otorhinolaryngology.

Professional Endeavors

Following his compulsory service in Sivas (1984–1986), Dr. Özturan specialized in Ear, Nose, and Throat (ENT) diseases at Istanbul University. His career trajectory advanced steadily, beginning as an ENT specialist at Adana SSK Hospital (1991–1993) and later transitioning to academia. His academic journey started at İnönü University, where he rose through the ranks from Assistant Professor (1993) to Associate Professor (1995) and Professor (2001). His leadership extended into key administrative positions, including department head roles and hospital executive responsibilities, reflecting both clinical and managerial expertise.

Contributions and Research Focus

Dr. Özturan’s research and clinical work span a wide range of ENT subspecialties, with particular emphasis on nasal congestion, sinusitis, functional and aesthetic nose surgeries, sleep apnea management, pediatric ENT conditions, hearing loss, cochlear implantation, vertigo, and laryngeal cancer. His professional interests also encompass advanced surgical interventions, including eardrum reconstruction, facial nerve surgeries, and salivary gland treatments. His global training in Australia, the USA, and Israel enhanced his expertise and broadened his research outlook.

Impact and Influence

As an internationally recognized figure, Dr. Özturan has contributed substantially to advancing otorhinolaryngology. With 251 publications in international journals and 79 in national outlets, his work reflects both breadth and depth. His active participation in 64 international and 224 national meetings demonstrates his role as a thought leader and mentor within the medical community. His administrative service-as Vice Rector, Ethics Committee Vice Chair, and Chair of the Academic Performance Monitoring Commission-illustrates his influence beyond the clinic, shaping institutional policies and academic growth.

Academic Citations

The academic impact of Dr. Özturan’s scholarship is demonstrated by his impressive citation metrics. As of August 8, 2025, his Google Scholar citation count stands at 5,066, with an h-index of 39 and an i10-index of 126. These figures not only reflect the consistent quality of his research but also his enduring influence in shaping scientific inquiry within ENT and allied fields.

Legacy and Future Contributions

Dr. Özturan’s legacy is defined by his dual commitment to clinical excellence and academic advancement. His pioneering work in nasal surgery, cochlear implants, and sleep apnea treatment has provided new pathways for therapeutic intervention. As a mentor and leader, he has guided students, researchers, and practitioners, ensuring the continuity of high standards in medical education and practice. Looking ahead, his ongoing involvement at Bezmialem Vakif University positions him to continue shaping ENT research and medical education, inspiring future generations of otorhinolaryngologists.

Conclusion

In sum, Dr. Orhan Özturan’s career reflects a rare combination of clinical expertise, research productivity, and academic leadership. His early academic brilliance matured into a distinguished professional life marked by innovation, international collaboration, and scholarly impact. With a strong legacy already established, his future contributions are poised to further strengthen the global discourse in otorhinolaryngology, making him a worthy candidate for recognition as a leading researcher in his field.

Notable Publications

“Effect of Medical Ozone Therapy in Preventing Compromised Nasal Skin in Revision Rhinoplasty" 

  • Author: A Alp, E Polat, A Yenigun, O Pasin, O Ozturan
  • Journal: Aesthetic Plastic Surgery
  • Year: 2025

“Radiologic prevalence of otic capsule dehiscence and development of the Yenigun classification for semicircular canal dehiscence" 

  • Author: A Yenigun, YB Polat, E Polat, S Balsak, M Basoz, SB Eren, O Ozturan
  • Journal: Auris Nasus Larynx
  • Year: 2025

“Intranasal Diclofenac Sodium, Ibuprofen and Paracetamol for Pain Relief After Pediatric Tonsillectomy" 

  • Author: A Yenigün, RB Küçük, MF Özgan, H Uysal, AA Sağıroğlu, VB YENİGÜN
  • Journal: International Journal of Pediatric Otorhinolaryngology
  • Year: 2025

“Enhancing Nasal Tip Projection and Stability with a Columellar Strut Graft Placed in a Mucosal Flap Pocket" 

  • Author: M Ceran, A Yenigun, E Polat, O Ozturan
  • Journal: JPRAS Open
  • Year: 2025

“Spectral resolution and speech comprehension performance in noise in individuals with multiple sclerosis" 

  • Author: ÖG Toker, E Kuru, N Tas Elibol, V Güzel, R Doğan, O Özturan
  • Journal: BMC neurology
  • Year: 2025

 

 

Cora Sternberg | Meta analysis | Outstanding Scientist Award

Published on by Network Science

Dr. Cora Sternberg | Meta analysis | Outstanding Scientist Award

Weill Cornell Medicine | United States

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Dr. Cora Sternberg’s academic journey reflects her commitment to excellence from the outset. She completed her medical training with distinction and pursued advanced fellowships, including a Research Fellowship in Immunology at the National Institutes of Health (1976–1977). Her early academic roles as Teaching Assistant at Stanford and Mount Sinai, followed by Clinical Instructor at Cornell University, laid the foundation for her lifelong dedication to education and clinical research. Her Phi Beta Kappa distinction from the University of Pennsylvania marked the start of a career dedicated to innovation and leadership in oncology.

Professional Endeavors

Over four decades, Dr. Sternberg has held prestigious academic and clinical leadership roles. She was Chief of Medical Oncology at San Camillo-Forlanini Hospital in Rome and served as Professor at La Sapienza University, shaping Italy’s oncology community. Since 2018, she has been Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine and New York-Presbyterian. She has also served as a global faculty member at Temple University, Tufts University, and European institutions.

Contributions and Research Focus

Dr. Sternberg has pioneered groundbreaking research in prostate cancer, bladder cancer, and renal cell carcinoma. She was instrumental in developing practice-changing therapies such as abiraterone, enzalutamide, and darolutamide, significantly improving survival outcomes for prostate cancer patients. Her work in urothelial cancer led to the establishment of M-VAC chemotherapy and global adoption of immunotherapy protocols. She also contributed to the development of pazopanib and other targeted therapies in renal cell carcinoma. Recently, she has expanded her research focus to artificial intelligence in oncology, spearheading initiatives to integrate AI into therapeutic decision-making.

Impact and Influence

With over 546 publications, six textbooks, and more than 45,200 citations, Dr. Sternberg ranks among the World’s Top 2% Scientists (Stanford University) and the top 5% in the Doximity community for citations. She has delivered more than 835 lectures worldwide, influencing clinical practice, policy, and guidelines in oncology. Her leadership roles in international organizations such as ASCO, ESMO, ECCO, and EORTC demonstrate her far-reaching influence.

Academic Citations

Dr. Sternberg’s research impact is widely recognized. Her publications in high-impact journals such as New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology have shaped global treatment standards. Her works are consistently cited in clinical guidelines, trial protocols, and oncology education, affirming her stature as a thought leader in medical oncology.

Legacy and Future Contributions

Dr. Sternberg’s legacy lies not only in transformative research but also in mentorship. She has nurtured generations of oncologists, fostering innovation and translational research. Currently, she co-leads the Career Development Program in the Bladder SPORE initiative, ensuring the pipeline of future oncology leaders. Her pioneering role in AI in oncology positions her to continue shaping the future of precision medicine, bridging clinical care with technological innovation.

Conclusion

Dr. Cora Sternberg exemplifies the qualities of an Outstanding Scientist—visionary leadership, transformative research, global influence, and unwavering dedication to advancing oncology. Her lifelong contributions to clinical practice, groundbreaking research, academic mentorship, and adoption of emerging technologies ensure her lasting impact on the medical community and future generations of scientists.

Notable Publications

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: homas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Cancers
  • Year: 2025

"The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making" 

  • Author: Olivier Elemento; Sean Khozin; Cora N. Sternberg
  • Journal: NEJM AI
  • Year: 2025

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: Thomas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Preprint
  • Year: 2025

"Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591" 

  • Author: Scott T. Tagawa; Charlene Thomas; A. Oliver Sartor; Michael Sun; Judith Stangl-Kremser; Mahelia Bissassar; Shankar Vallabhajosula; Sandra Huicochea Castellanos; Jones T. Nauseef; Cora N. Sternberg et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2024

"Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial" 

  • Author: Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N. Sternberg; E. David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2023